Do you want to read an article? Please log in or register.
Systemic and intracranial activity of antibody-drug conjugates in patients with non-small cell lung cancer and brain metastases: A systematic review and meta-analysis
Lung Cancer
Related content
Lung Cancer
Pretreatment eosinophilia as a biomarker for adverse outcomes in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis
Semin Oncol
Ganatra N, Thompson J, Desai R, Doshi J, Jain P, Pasnoor DS, Jain A
doi: 10.1016/j.seminoncol.2025.152431
Lung Cancer
Impact of Histology and PD-L1 Status on Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer a Systemic Review and Meta-analysis
Clin Lung Cancer
Choucair K, Jang H, Jalal SI, Hadid T, Uprety D, Kim S, Mamdani H
doi: 10.1016/j.cllc.2025.10.014
Lung Cancer
Systematic review and network meta-analysis: evaluation of systemic therapies for platinum refractory or resistant small cell lung cancer
Lung Cancer
Desai RK, Zhou EJ, Chan KKW
doi: 10.1016/j.lungcan.2025.108812
RECOMMENDED
Lung Cancer
Comparative efficacy and safety of post-TKI treatments for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and network meta-analysis
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Wang Y, Zhang L, Zhan J, Wen L, Zhao X, Sun H, Chen X, Zhang Y, Chen G, Zhao Y, Huang Y, Fang W, Zhang L, Sun D, Yang Y
doi: 10.1016/j.lungcan.2026.108914
RECOMMENDED
Lung Cancer
Real-world incidence, prevalence, and clinical impact of brain metastases in patients with ALK-positive metastatic non-small cell lung cancer treated with first-line ALK tyrosine kinase inhibitors
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Liu G, Abrahami D, Ramachandran P, Messina R, Rifi N, Yang H, Chai X, Li B, Ramaswamy K, Iyengar P, Pennell NA, Shaw AT
doi: 10.1016/j.lungcan.2025.108858
Lung Cancer
First-line immunotherapy ± chemotherapy with or without upfront stereotactic radiotherapy (SRT) in patients with Non-Small cell lung cancer (NSCLC) with asymptomatic brain metastases
Lung Cancer
Frehner L, Schär S, Hayoz S, Petermichl V, Speicher P, I Rothschild S, Mauti LA, König D, Finazzi T, Froesch P, Marini S, Allemann A, Mark M, Janthur WD, Stamatiou A, Metaxas Y, Ermiş E, Wagner F, Früh M, Schmid S
doi: 10.1016/j.lungcan.2025.108813
Lung Cancer
Brain Metabolic Activity Measured by [(18)F]FDG PET/CT Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer
J Nucl Med
Auriac J, Lemoudda G, Hovhannisyan-Baghdasarian N, Pires M, Shiyam Sundar LK, Salamoun-Feghali P, Seban RD, Jehanno N, Nioche C, Luporsi M, Beyer T, Livartowski A, Girard N, Buvat I, Orlhac F
doi: 10.2967/jnumed.125.271400
Lung Cancer
Associated factors regarding systemic anticancer therapy use prior to death among patients with metastatic non-small cell lung cancer: A multicentre retrospective cohort study
Lung Cancer
Mokkenstorm K, van Beusekom S, Breukhoven C, Veldman A, Pustjens S, Dijkstra N, Bos-Gerkema M, Kunst P, Smit A, Geerse O, Santeon VBHC lung cancer group
doi: 10.1016/j.lungcan.2026.109551
RECOMMENDED
Lung Cancer
Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Clin Lung Cancer
Liu Y, Li D, Wu L, Li X, Fan Y, Zhang M, Guo J, Yao Y, Fang J, Tang KJ, Luo F, Yu Y, Min X, Song Z, Hu J, Ma R, Yang H, Shu Y, Xu R, Wang B, Dong X, Chen Y, Mao R, Zhang V, Fang Y
doi: 10.1016/j.cllc.2026.06.003